DK2158908T3 - Sammensætning til transdermal administrering - Google Patents
Sammensætning til transdermal administreringInfo
- Publication number
- DK2158908T3 DK2158908T3 DK08777444.4T DK08777444T DK2158908T3 DK 2158908 T3 DK2158908 T3 DK 2158908T3 DK 08777444 T DK08777444 T DK 08777444T DK 2158908 T3 DK2158908 T3 DK 2158908T3
- Authority
- DK
- Denmark
- Prior art keywords
- composition
- transdermal administration
- transdermal
- administration
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007163692 | 2007-06-21 | ||
| PCT/JP2008/061300 WO2008156160A1 (ja) | 2007-06-21 | 2008-06-20 | 経皮または経粘膜投与用組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2158908T3 true DK2158908T3 (da) | 2013-07-29 |
Family
ID=40156318
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK08777444.4T DK2158908T3 (da) | 2007-06-21 | 2008-06-20 | Sammensætning til transdermal administrering |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20100137429A1 (da) |
| EP (1) | EP2158908B1 (da) |
| JP (1) | JP5754885B2 (da) |
| KR (1) | KR101500022B1 (da) |
| CN (1) | CN101677988A (da) |
| AU (1) | AU2008264476B2 (da) |
| CA (1) | CA2690945C (da) |
| DK (1) | DK2158908T3 (da) |
| ES (1) | ES2409554T3 (da) |
| IL (1) | IL202221A (da) |
| PT (1) | PT2158908E (da) |
| SI (1) | SI2158908T1 (da) |
| WO (1) | WO2008156160A1 (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5820207B2 (ja) | 2011-09-13 | 2015-11-24 | 日東電工株式会社 | 経皮吸収促進用組成物および貼付製剤 |
| JP5820206B2 (ja) * | 2011-09-13 | 2015-11-24 | 日東電工株式会社 | 経皮吸収促進用組成物および貼付製剤 |
| KR102198540B1 (ko) * | 2015-11-25 | 2021-01-06 | 삼성전기주식회사 | 적층 세라믹 커패시터 및 그 실장 기판 |
| WO2018175969A1 (en) * | 2017-03-24 | 2018-09-27 | Intra-Cellular Therapies, Inc. | Novel compositions and methods |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4943435A (en) * | 1987-10-05 | 1990-07-24 | Pharmetrix Corporation | Prolonged activity nicotine patch |
| GB8807504D0 (en) * | 1988-03-29 | 1988-05-05 | Sandoz Ltd | Improvements in/relating to organic compounds |
| US5879690A (en) * | 1995-09-07 | 1999-03-09 | Perricone; Nicholas V. | Topical administration of catecholamines and related compounds to subcutaneous muscle tissue using percutaneous penetration enhancers |
| KR100572900B1 (ko) * | 1997-08-07 | 2006-04-24 | 후지모토 쿄다이 가부시키가이샤 | 에틸아민 유도체 |
| JP4499208B2 (ja) * | 1998-10-29 | 2010-07-07 | 株式会社フジモト・コーポレーション | 新規な光学活性アミノペンタン誘導体 |
| KR100674108B1 (ko) * | 1999-04-13 | 2007-01-26 | 히사미쓰 세이야꾸 가부시키가이샤 | 경피흡수형 제제 |
| DE19934592C2 (de) | 1999-07-23 | 2003-10-23 | Benckiser Nv | Vorrichtung zur Aufnahme und dosierten Abgabe einer aktiven Zusammensetzung in eine Waschmaschine, einen Wäschetrockner oder eine Geschirrspülmaschine |
| RU2282468C2 (ru) * | 2000-10-26 | 2006-08-27 | Алза Корпорейшн | Устройство для трансдермальной доставки лекарственных средств, имеющее микровыступы с покрытием |
| US20020192821A1 (en) * | 2001-05-22 | 2002-12-19 | Active Pass Pharmaceuticals, Inc. | Increased functional activity and/or expression of ABC transporters protects against the loss of dopamine neurons associated with Parkinson's disease |
| JP4953040B2 (ja) | 2001-09-19 | 2012-06-13 | 株式会社フジモト・コーポレーション | アポトーシス抑制剤 |
| US7429258B2 (en) * | 2001-10-26 | 2008-09-30 | Massachusetts Institute Of Technology | Microneedle transport device |
| JP5030194B2 (ja) * | 2004-11-25 | 2012-09-19 | 国立大学法人九州大学 | 薬物依存症治療剤 |
| WO2006082888A1 (ja) | 2005-02-03 | 2006-08-10 | Kyorin Pharmaceutical Co., Ltd. | 経皮吸収型製剤 |
-
2008
- 2008-06-20 CA CA2690945A patent/CA2690945C/en not_active Expired - Fee Related
- 2008-06-20 CN CN200880021157A patent/CN101677988A/zh active Pending
- 2008-06-20 AU AU2008264476A patent/AU2008264476B2/en not_active Ceased
- 2008-06-20 ES ES08777444T patent/ES2409554T3/es active Active
- 2008-06-20 EP EP08777444.4A patent/EP2158908B1/en active Active
- 2008-06-20 DK DK08777444.4T patent/DK2158908T3/da active
- 2008-06-20 JP JP2009520548A patent/JP5754885B2/ja not_active Expired - Fee Related
- 2008-06-20 PT PT87774444T patent/PT2158908E/pt unknown
- 2008-06-20 SI SI200830982T patent/SI2158908T1/sl unknown
- 2008-06-20 KR KR1020097026617A patent/KR101500022B1/ko not_active Expired - Fee Related
- 2008-06-20 WO PCT/JP2008/061300 patent/WO2008156160A1/ja not_active Ceased
- 2008-06-20 US US12/452,239 patent/US20100137429A1/en not_active Abandoned
-
2009
- 2009-11-19 IL IL202221A patent/IL202221A/en active IP Right Grant
-
2012
- 2012-08-13 US US13/572,987 patent/US20130005800A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ES2409554T3 (es) | 2013-06-27 |
| US20130005800A1 (en) | 2013-01-03 |
| CN101677988A (zh) | 2010-03-24 |
| US20100137429A1 (en) | 2010-06-03 |
| HK1139052A1 (en) | 2010-09-10 |
| PT2158908E (pt) | 2013-05-07 |
| AU2008264476A1 (en) | 2008-12-24 |
| KR20100023884A (ko) | 2010-03-04 |
| CA2690945A1 (en) | 2008-12-24 |
| EP2158908A1 (en) | 2010-03-03 |
| EP2158908A4 (en) | 2011-03-30 |
| IL202221A (en) | 2017-04-30 |
| JPWO2008156160A1 (ja) | 2010-08-26 |
| AU2008264476B2 (en) | 2013-03-28 |
| CA2690945C (en) | 2015-07-21 |
| JP5754885B2 (ja) | 2015-07-29 |
| EP2158908B1 (en) | 2013-04-24 |
| SI2158908T1 (sl) | 2013-07-31 |
| WO2008156160A1 (ja) | 2008-12-24 |
| KR101500022B1 (ko) | 2015-03-06 |
| IL202221A0 (en) | 2010-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTPA2018005I1 (lt) | Farmacinė kompozicija | |
| LTPA2018014I1 (lt) | Farmacinė kompozicija 514 | |
| DK2345410T3 (da) | Farmaceutisk sammensætning til modificeret frigivelse | |
| BRPI0721651A2 (pt) | Composição farmacêutica | |
| DK2274032T3 (da) | Anordning til medicinindgivelse | |
| DK2173407T3 (da) | Anordning til indgivelse af lægemiddel | |
| DK2219603T3 (da) | Transdermalt afgivelsessystem | |
| BRPI0906962A2 (pt) | Composto, e, composição farmacêutica | |
| BRPI0906556A2 (pt) | Composto, e, composição farmacêutica | |
| DK2117521T3 (da) | Transdermale indgivelsessystemer omfattende bupivacain | |
| DK3492069T3 (da) | Farmaceutiske sammensætninger omfattende jern-oxy-hydroxid | |
| DK2120884T3 (da) | Farmaceutisk sammensætning | |
| BRPI0813775A2 (pt) | Composição | |
| ATE528048T1 (de) | Schweisshemmende/desodorierende zusammensetzung | |
| DK2285413T3 (da) | Farmaceutisk sammensætning | |
| BRPI0917681A2 (pt) | Composto, e, composição farmacêutica | |
| EP2236149A4 (en) | MEDICAL COMPOSITION | |
| BRPI0910901A2 (pt) | composição farmacêutica com bisfosfonato | |
| BRPI0811274A2 (pt) | Composição | |
| BRPI0810557A2 (pt) | composição | |
| BRPI0921313A2 (pt) | composição farmaucêutica | |
| PT2209464E (pt) | Composição farmacêutica antimalárica | |
| DK2307020T3 (da) | Administrationsskema til nitrocatecholer | |
| EP2343979A4 (en) | TRANSDERMALE ADMINISTRATION | |
| DK2271618T3 (da) | Farmaceutiske forbindelser |